| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations
|
Schröder, Katharina
|
|
2015
|
|
5 |
p. 406-408
|
artikel
|
| 2 |
Announcement
|
|
|
2015
|
|
5 |
p. vi
|
artikel
|
| 3 |
Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model
|
Ramachandran, Sudarshan
|
|
2014
|
|
5 |
p. 593-599
7 p.
|
artikel
|
| 4 |
A web-based decision support tool for prognosis simulation in multiple sclerosis
|
Veloso, Mário
|
|
2014
|
|
5 |
p. 575-583
9 p.
|
artikel
|
| 5 |
Causes of death among persons with multiple sclerosis
|
Cutter, Gary R.
|
|
2015
|
|
5 |
p. 484-490
|
artikel
|
| 6 |
CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination
|
Holley, Janet E.
|
|
2014
|
|
5 |
p. 650-658
9 p.
|
artikel
|
| 7 |
Clinical and radiological features of recurrent demyelination following acute disseminated encephalomyelitis (ADEM)
|
Kariyawasam, Sanduni
|
|
2015
|
|
5 |
p. 451-456
|
artikel
|
| 8 |
Comorbidity is associated with pain-related activity limitations in multiple sclerosis
|
Fiest, K.M.
|
|
2015
|
|
5 |
p. 470-476
|
artikel
|
| 9 |
Continuous prediction of secondary progression in the individual course of multiple sclerosis
|
Skoog, Bengt
|
|
2014
|
|
5 |
p. 584-592
9 p.
|
artikel
|
| 10 |
Corrigendum to “The case for vitamin D supplementation in multiple sclerosis” [Mult. Scler. Relat. Disord. 2 (2013) 281–306]
|
Ganesh, Aravind
|
|
2014
|
|
5 |
p. 666-
1 p.
|
artikel
|
| 11 |
EAE is not a useful model for demyelinating disease
|
Behan, Peter O.
|
|
2014
|
|
5 |
p. 565-574
10 p.
|
artikel
|
| 12 |
Editors׳ welcome
|
Banwell, Brenda
|
|
2014
|
|
5 |
p. 553-554
2 p.
|
artikel
|
| 13 |
Editors' Welcome
|
Banwell, Brenda
|
|
2015
|
|
5 |
p. A1-A2
|
artikel
|
| 14 |
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report
|
Harirchian, M.H.
|
|
2015
|
|
5 |
p. 400-402
|
artikel
|
| 15 |
Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely
|
Baker, David
|
|
2014
|
|
5 |
p. 555-564
10 p.
|
artikel
|
| 16 |
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis
|
Hughes, Bruce
|
|
2014
|
|
5 |
p. 620-628
9 p.
|
artikel
|
| 17 |
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies
|
DiMarco, John P.
|
|
2014
|
|
5 |
p. 629-638
10 p.
|
artikel
|
| 18 |
Identifying employed multiple sclerosis patients at-risk for job loss: When do negative work events pose a threat?
|
Kordovski, Victoria M.
|
|
2015
|
|
5 |
p. 409-413
|
artikel
|
| 19 |
Immune reconstitution inflammatory syndrome and natalizumab–Is it possible before removing the drug?
|
Mulero, P.
|
|
2014
|
|
5 |
p. 659-661
3 p.
|
artikel
|
| 20 |
InMS: Chronic insomnia disorder in multiple sclerosis – a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life
|
Viana, Pedro
|
|
2015
|
|
5 |
p. 477-483
|
artikel
|
| 21 |
Longitudinally extensive transverse myelitis suspected for isolated Neuro-Behçet: A diagnostic conundrum
|
Al Sawaf, Abdullah
|
|
2015
|
|
5 |
p. 395-399
|
artikel
|
| 22 |
Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis
|
MacLean, Heather J.
|
|
2015
|
|
5 |
p. 414-429
|
artikel
|
| 23 |
Optimizing therapy early in multiple sclerosis: An evidence-based view
|
Ziemssen, Tjalf
|
|
2015
|
|
5 |
p. 460-469
|
artikel
|
| 24 |
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction
|
Zimmer, Andrea
|
|
2015
|
|
5 |
p. 444-450
|
artikel
|
| 25 |
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis
|
Fox, Edward
|
|
2014
|
|
5 |
p. 607-619
13 p.
|
artikel
|
| 26 |
Physical and social environment and the risk of multiple sclerosis
|
Magyari, Melinda
|
|
2014
|
|
5 |
p. 600-606
7 p.
|
artikel
|
| 27 |
P wave duration and dispersion and QT interval in multiple sclerosis
|
Razazian, Nazanin
|
|
2014
|
|
5 |
p. 662-665
4 p.
|
artikel
|
| 28 |
Risk stratification and mitigation in multiple sclerosis
|
Ontaneda, Daniel
|
|
2014
|
|
5 |
p. 639-649
11 p.
|
artikel
|
| 29 |
Sleep bruxism possibly triggered by multiple sclerosis attacks and treated successfully with botulinum toxin: Report of three cases
|
Sevim, Serhan
|
|
2015
|
|
5 |
p. 403-405
|
artikel
|
| 30 |
Stopping immunomodulatory medications in MS: Frequency, reasons and consequences
|
Tobin, W.O.
|
|
2015
|
|
5 |
p. 437-443
|
artikel
|
| 31 |
Successful treatment of paroxysmal tonic spasms with topiramate in a patient with neuromyelitis optica
|
Iida, Shin
|
|
2015
|
|
5 |
p. 457-459
|
artikel
|
| 32 |
The analysis of semantic networks in multiple sclerosis identifies preferential damage of long-range connectivity
|
Abad, Elena
|
|
2015
|
|
5 |
p. 387-394
|
artikel
|
| 33 |
The use of transcranial magnetic stimulation in diagnosis, prognostication and treatment evaluation in multiple sclerosis
|
Simpson, Marion
|
|
2015
|
|
5 |
p. 430-436
|
artikel
|
Tijdschrift beschrijving